Finance

Lists
SENORES:NSE
Senores Pharmaceuticals Ltd
1 381,00 INR
-1,62%
(-22,70) 1D
30 სექ, 12:58:19 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SENORES...
Open
1 403,70 INR
High
1 413,00 INR
Low
1 370,00 INR
Mkt. cap
63,60 მლრდ.
Avg. vol.
227,79 ათ.
Volume
156,45 ათ.
P/E ratio
51,08
52-wk high
1 599,00 INR
52-wk low
684,60 INR
EPS
27,03 INR
No. of employees
368
Open
1 403,70 INR
High
1 413,00 INR
Low
1 370,00 INR
Mkt. cap
63,60 მლრდ.
Avg. vol.
227,79 ათ.
Volume
156,45 ათ.
P/E ratio
51,08
52-wk high
1 599,00 INR
52-wk low
684,60 INR
EPS
27,03 INR
No. of employees
368
About Senores Pharmaceuticals Ltd
CEO-
Employees368
Founded2017
Headquarters-
SectorPharmaceutical industry
Websitesenorespharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,53 მლრდ.
1,65 მლრდ.
1,75 მლრდ.
1,80 მლრდ.
Cost of goods sold
570,80 მლნ.
670,20 მლნ.
662,20 მლნ.
657,20 მლნ.
Cost of revenue
570,80 მლნ.
670,20 მლნ.
662,20 მლნ.
657,20 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
296,30 მლნ.
306,60 მლნ.
303,20 მლნ.
299,10 მლნ.
Operating expense
548,70 მლნ.
517,00 მლნ.
707,80 მლნ.
706,70 მლნ.
Total operating expenses
1,12 მლრდ.
1,19 მლრდ.
1,37 მლრდ.
1,36 მლრდ.
Operating income
414,10 მლნ.
461,40 მლნ.
381,90 მლნ.
438,20 მლნ.
Other non operating income
54,10 მლნ.
37,90 მლნ.
176,70 მლნ.
28,10 მლნ.
EBT including unusual items
406,30 მლნ.
446,00 მლნ.
474,00 მლნ.
394,60 მლნ.
EBT excluding unusual items
406,30 მლნ.
446,00 მლნ.
474,00 მლნ.
394,60 მლნ.
Income tax expense
105,10 მლნ.
110,20 მლნ.
107,30 მლნ.
90,10 მლნ.
Effective tax rate
25,87%
24,71%
22,64%
22,83%
Other operating expenses
171,50 მლნ.
131,80 მლნ.
311,60 მლნ.
308,20 მლნ.
Net income
323,80 მლნ.
316,60 მლნ.
316,10 მლნ.
307,20 მლნ.
Net profit margin
21,11%
19,20%
18,04%
17,05%
Earnings per share
6,54
7,29
7,96
6,60
Interest and investment income
-
-
-
-
Interest expense
-61,90 მლნ.
-53,30 მლნ.
-84,60 მლნ.
-71,70 მლნ.
Net interest expenses
-61,90 მლნ.
-53,30 მლნ.
-84,60 მლნ.
-71,70 მლნ.
Depreciation and amortization charges
80,90 მლნ.
78,60 მლნ.
93,00 მლნ.
99,40 მლნ.
EBITDA
484,55 მლნ.
499,80 მლნ.
460,02 მლნ.
516,32 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები